Skip to main content

Artificial intelligence could be new blueprint for precision drug discovery


 

The University of California, the San Diego School of Medicine, describes a new method that uses machine learning to target disease targets and predicts whether a drug can obtain FDA approval. The findings of the study could drastically change how researchers sift through large amounts of data to obtain valuable information that is of great benefit to patients, the pharmaceutical industry, and national health care systems.

“This is primarily a drug that works perfectly on the preterm birth side that is similar or similar. This is a clinical case that is considered to be the Achilles' heel of any drug discovery system. ”

The availability of drugs, in the current situation, is costly and has a high level of attraction, which puts a lot of pressure on the industry to address this challenge. One area of ​​high fall translates from pre-trial testing to clinical trials, where drugs that usually work well in inbred preclinical models, such as mice, do not translate into clinical patients, perhaps due to high variability and disease personality from one patient to another.

Now, researchers at the University of California San Diego, USA, led by Pradipta Ghosh, Soumita Das, and Debashis Sahoo have used a model of inflammatory bowel disease (IBD), using their two novel methods, instead of the first and last steps of drug discovery. before surgery. The first step called target identification used the artificial intelligence (AI) method that created a genetic map that extracted information that applied to all IBD patients and was used to find potential drug goals. The final step, called target validation for preoperative models, was performed for the first time in a Phase '0' clinical trial using a live biobank of organoids performed on IBD patients.

Researchers have found that the use of computers has a surprisingly high level of accuracy in various groups of IBD patients, and in line with Phase '0', they developed the first-class treatment to restore and protect the leaky water barrier in IBD.

The authors claim that the following steps include testing whether a drug that passed a '0 'human trial in a container can pass phase III tests at a clinic; and whether the same methods can be used with other diseases, from various cancers and Alzheimer's disease to non-alcoholic fatty acids.

"Our program has the potential to undermine the current situation and provide better treatment for chronic diseases that do not have the best treatment options," Ghosh said.

The approach could provide the predictive horsepower that will help doctors understand how diseases progress, assess a drug’s potential benefits and strategize how to use a combination of therapies when current treatment is failing.

Comments

Popular posts from this blog

Pegasus Spyware: Flying Through The Air

 Hundreds of millions of people can't imagine life without their smartphones. Almost every aspect of their daily lives, from the most mundane to the most intimate, is within easy reach and hearing distance of their smartphones. Only few people realize that their phones may be used as surveillance devices, with someone hundreds of miles away secretly extracting their messages, photographs, and location while also activating their microphone and recording them in real time. Such capabilities are present in Pegasus, a spyware produced by NSO Group, an Israeli maker of mass surveillance weapons. What is Pegasus? Pegasus is a hacking software – or spyware – that is developed, marketed and licensed to governments around the world by the Israeli company NSO Group. It has the capability to infect billions of phones using either iOS or Android operating systems. The spyware is named after Pegasus, the white winged horse from Greek mythology. It is named so because it "flies through the...

Unhackable Internet

  W hy it matters?   The internet is increasingly vulnerable to hacking; a quantum one would be unhackable. Quantum Computing    A quantum internet could be used to send unhackable messages, improve the accuracy of GPS, and enable cloud-based quantum computing. For more than twenty years, dreams of creating such a the quantum network have remained out of reach in large part because of the difficulty to send quantum signals across large distances without loss.   Now, Harvard and MIT researchers have found a way to correct for signal loss with a prototype quantum node that can catch, store and entangle bits of quantum information. The research is the missing link towards a practical quantum internet and a major step forward in the development of long-distance quantum networks.   The U.S Department of Energy (DoE) explains how a quantum link will make it happen through two quantum phenomenon: the first is quantum entanglement, where two-particle ...

3D LASER SCANNING

  What is 3D Scanning? 3D Laser Scanning is a non-contact, non-destructive technology that uses a line of laser light to digitally capture the shape of physical objects. 3D laser scanners generate "point clouds" of data from an object's surface. In other words, 3D laser scanning is a method of capturing the exact size and shape of a physical object into the computer world as a digital 3-dimensional representation. 3D laser scanners capture free-form shapes and measure fine details to quickly generate highly accurate point clouds. 3D laser scanning is ideal for the measurement and inspection of contoured surfaces and complex geometries that require massive amounts of data for accurate description and where using traditional measurement methods or a touch probe is impractical.process :3D Laser Scanning Data Acquisition. CLASSIFICATION 1. No Contact Scanning: Millions of points on the xyz coordinate system can be easily captured via non-contact scanning. This data prov...